Abstract We110: Novel Allosteric Ligand Designed to Prevent Autoantibody Targeting the Angiotensin Type 1 Receptor (AT1R) in Cardiovascular Diseases (CVD)
Circulation Research（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined